Advanced Search

Technical Analysis for OXFD - Oxford Immunotec Global PLC

Grade Last Price % Change Price Change
B 21.99 0.05% 0.01
OXFD closed up 0.05 percent on Friday, March 5, 2021, on 81 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Flat
Historical OXFD trend table...
Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 27.18%
Doji - Bearish? Reversal 27.18%
Doji - Bearish? Reversal 25.59%
Up 3 Days in a Row Strength 25.59%
Outside Day Range Expansion 25.95%
MACD Bearish Signal Line Cross Bearish 30.66%
Narrow Range Bar Range Contraction 30.66%
NR7 Range Contraction 30.66%
Doji - Bullish? Reversal 30.66%
Outside Day Range Expansion 30.04%
Older End-of-Day Signals for OXFD ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators Basic chart:

Profile

Oxford Immunotec Global PLC, a diagnostics company, focuses on the provision of various innovative tests in the field of immunology in the United States, Europe, Japan, and China. The company develops its products using its T-SPOT technology platform, which allows to measure the responses of specific immune cells to inform the diagnosis, prognosis, and monitoring of patients with immunologically controlled diseases. Its solution includes SPOT.TB test, a single-cell based method for identifying latent tuberculosis infection. The company was founded in 2013 and is headquartered in Abingdon, the United Kingdom.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Immunology Infection Immunity Tuberculosis Tb

Is OXFD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Mar 4 Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection
Mar 4 PerkinElmer, Inc. -- Moody's assigns Baa3 rating to PerkinElmer's notes offering
Feb 17 INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - RP, CUB, CRHM, OXFD, FLIR, CBLI, AJRD
Feb 14 Lifshitz Law Firm, P.C. Announces Investigation of CHNG, MGLN, OBLN, and OXFD
Feb 10 INVESTIGATION ALERT: Halper Sadeh LLP Investigates CUB, CRHM, GLUU, OXFD, OBLN; Shareholders Are Encouraged to Contact the Firm
Feb 9 OXFORD IMMUNOTEC INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Oxford Immunotec Global PLC - OXFD
Feb 8 Oxford signs MOU with Green Cross Medical for T-SPOT Discovery SARS-CoV-2 kit
Feb 8 Oxford Immunotec Enters a Memorandum of Understanding (MOU) with GC MS (Green Cross Medical Science Corp. – South Korea) to Market the T-SPOT® Discovery SARS-CoV-2 Kit, for the Measurement of the T Cell Immune Response to SARS-CoV-2 Infection, in South...
Feb 7 Lifshitz Law Firm, P.C. Announces Investigation of CHNG, CPAH, HMSY, INFO, MGLN, NAV, OBLN, OXFD, and WTRE
Feb 4 Oxford Immunotec updates T-SPOT COVID-19 test kit with new panel
See more OXFD news...

Indicators

Indicator Value
52 Week High 23.1081
52 Week Low 8.37
Average Volume 991,654
200-Day Moving Average 15.28
50-Day Moving Average 21.00
20-Day Moving Average 21.95
10-Day Moving Average 21.95
Average True Range 0.13
ADX 69.48
+DI 32.10
-DI 7.16
Chandelier Exit (Long, 3 ATRs ) 21.64
Chandelier Exit (Short, 3 ATRs ) 22.24
Upper Bollinger Band 22.00
Lower Bollinger Band 21.90
Percent B (%b) 0.92
BandWidth 0.46
MACD Line 0.26
MACD Signal Line 0.36
MACD Histogram -0.1
Fundamentals Value
Market Cap 570.9 Million
Num Shares 26 Million
EPS 5.18
Price-to-Earnings (P/E) Ratio 4.25
Price-to-Sales 6.59
Price-to-Book 1.97
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.02
Resistance 3 (R3) 22.02 22.00 22.02
Resistance 2 (R2) 22.00 22.00 22.01 22.01
Resistance 1 (R1) 22.00 21.99 22.00 22.00 22.01
Pivot Point 21.98 21.98 21.99 21.99 21.98
Support 1 (S1) 21.98 21.98 21.98 21.98 21.97
Support 2 (S2) 21.96 21.97 21.97 21.97
Support 3 (S3) 21.96 21.96 21.97
Support 4 (S4) 21.96